• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国草药肝毒性的研究进展

Research Advances on Hepatotoxicity of Herbal Medicines in China.

作者信息

Liu Changxiao, Fan Huirong, Li Yazhuo, Xiao Xiaohe

机构信息

Research Center for New Drug Evaluation, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China.

Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China.

出版信息

Biomed Res Int. 2016;2016:7150391. doi: 10.1155/2016/7150391. Epub 2016 Dec 18.

DOI:10.1155/2016/7150391
PMID:28078299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5203888/
Abstract

In general, herbal medicines have been considered as safe by the general public, since they are naturally occurring and have been applied in treatment for over thousands of years. As the use of herbal medicine is rapidly increasing globally, the potential toxicity of herbal drugs, in particular drug-induced liver injury (DILI), has now become a serious medical issue. According to the literature, the authors analyzed and discussed the hepatotoxicity problem of Chinese herbal medicines (CHM), including global overview on herbal-induced liver injury (HILI), current research progress on toxic CHM, diagnosis and treatment of HILI, and modern approaches and technologies of study of hepatotoxicity. As to promote the recognition of HILI and tackle the issue, a guideline for the diagnosis and treatment of HILI has recently been drafted by Chinese scientists. As suggested by the guideline, the hepatotoxicity issue of CHM, as a matter of fact, is overestimated. Up to date, the investigation of hepatotoxicity of CHM is now booming with worldwide application of CHM. This review therefore provides useful information for investigating hepatotoxicity of herbal medicine and characterizing DILI caused by CHM. In addition, authors describe in which way further efforts should be made to study the rationale of CHM and liver injury.

摘要

总体而言,草药一直被公众认为是安全的,因为它们天然存在且已应用于治疗逾数千年。随着草药在全球的使用迅速增加,草药药物的潜在毒性,尤其是药物性肝损伤(DILI),现已成为一个严重的医学问题。根据文献,作者分析并讨论了中草药(CHM)的肝毒性问题,包括草药性肝损伤(HILI)的全球概况、有毒中草药的当前研究进展、HILI的诊断和治疗,以及肝毒性研究的现代方法和技术。为了提高对HILI的认识并解决该问题,中国科学家最近起草了一份HILI诊断和治疗指南。正如该指南所指出的,事实上,CHM的肝毒性问题被高估了。迄今为止,随着CHM在全球的广泛应用,对CHM肝毒性的研究正在蓬勃发展。因此,本综述为研究草药肝毒性和表征由CHM引起的DILI提供了有用信息。此外,作者描述了应如何进一步努力研究CHM与肝损伤之间的原理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/79a33cfa6e33/BMRI2016-7150391.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/d79ea151b8d1/BMRI2016-7150391.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/be2a9753d051/BMRI2016-7150391.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/c15dc50058c3/BMRI2016-7150391.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/fee39e0de4ae/BMRI2016-7150391.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/79a33cfa6e33/BMRI2016-7150391.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/d79ea151b8d1/BMRI2016-7150391.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/be2a9753d051/BMRI2016-7150391.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/c15dc50058c3/BMRI2016-7150391.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/fee39e0de4ae/BMRI2016-7150391.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0056/5203888/79a33cfa6e33/BMRI2016-7150391.005.jpg

相似文献

1
Research Advances on Hepatotoxicity of Herbal Medicines in China.中国草药肝毒性的研究进展
Biomed Res Int. 2016;2016:7150391. doi: 10.1155/2016/7150391. Epub 2016 Dec 18.
2
Chinese Herbal Medicine Hepatotoxicity: The Evaluation and Recognization Based on Large-scale Evidence Database.中草药肝毒性:基于大规模证据数据库的评估与识别。
Curr Drug Metab. 2019;20(2):138-146. doi: 10.2174/1389200219666180813144114.
3
Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.肝胆胰:1985例患者中药与西药所致肝损伤的比较
J Gastroenterol Hepatol. 2016 Aug;31(8):1476-82. doi: 10.1111/jgh.13323.
4
Systematic review on herb-induced liver injury in Korea.韩国草药性肝损伤的系统评价。
Food Chem Toxicol. 2015 Oct;84:47-54. doi: 10.1016/j.fct.2015.06.004. Epub 2015 Jul 10.
5
Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.在中国的两家医院中,使用更新的 RUCAM 评估药物和草药引起的肝损伤的流行病学。
Biomed Res Int. 2021 Feb 24;2021:8894498. doi: 10.1155/2021/8894498. eCollection 2021.
6
Herbal hepatotoxicity: current status, examples, and challenges.草药肝毒性:现状、实例与挑战。
Expert Opin Drug Metab Toxicol. 2015;11(10):1551-65. doi: 10.1517/17425255.2015.1064110. Epub 2015 Jul 6.
7
Differences in clinical characteristics among 726 patients with Chinese herbal medicine- or Western medicine-induced liver injury.726 例中药或西药所致肝损伤患者的临床特征差异。
Medicine (Baltimore). 2022 Aug 12;101(32):e29909. doi: 10.1097/MD.0000000000029909.
8
Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation.草药肝毒性:临床特征与列表汇编
Int J Mol Sci. 2016 Apr 27;17(5):588. doi: 10.3390/ijms17050588.
9
Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations.综述文章:草药性肝毒性——中药制剂的最新进展。
Aliment Pharmacol Ther. 2014 Jul;40(1):32-50. doi: 10.1111/apt.12798. Epub 2014 May 20.
10
Safety of co-administration of herbal and conventional medicines on liver and kidney function in stroke patients: A single-center retrospective study.中药与西药联合使用对脑卒中患者肝肾功能安全性的影响:一项单中心回顾性研究。
Phytomedicine. 2021 Jan;81:153435. doi: 10.1016/j.phymed.2020.153435. Epub 2020 Dec 6.

引用本文的文献

1
Analysis of the effects of acetyl tributyl citrate on bone cancer based on network toxicology and molecular docking.基于网络毒理学和分子对接的柠檬酸三丁酯对骨癌影响的分析
Front Med (Lausanne). 2025 Jun 23;12:1613657. doi: 10.3389/fmed.2025.1613657. eCollection 2025.
2
A case report of liver failure caused by Tetrastigma hemsleyanum Diels et Gilg: A rare case report and literature review.三叶崖爬藤致肝衰竭 1 例报告:罕见病例报告及文献复习
Medicine (Baltimore). 2025 Mar 28;104(13):e42059. doi: 10.1097/MD.0000000000042059.
3
Shengxue Busui Decoction activates the PI3K/Akt and VEGF pathways, enhancing vascular function and inhibiting osteocyte apoptosis to combat steroid-induced femoral head necrosis.

本文引用的文献

1
In Vitro Model for Hepatotoxicity Studies Based on Primary Human Hepatocyte Cultivation in a Perfused 3D Bioreactor System.基于灌注式3D生物反应器系统中原代人肝细胞培养的肝毒性研究体外模型
Int J Mol Sci. 2016 Apr 16;17(4):584. doi: 10.3390/ijms17040584.
2
Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients.肝胆胰:1985例患者中药与西药所致肝损伤的比较
J Gastroenterol Hepatol. 2016 Aug;31(8):1476-82. doi: 10.1111/jgh.13323.
3
Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review.
生血补髓汤激活PI3K/Akt和VEGF通路,增强血管功能并抑制骨细胞凋亡,以对抗类固醇诱导的股骨头坏死。
Front Pharmacol. 2025 Jan 24;15:1506594. doi: 10.3389/fphar.2024.1506594. eCollection 2024.
4
Investigating the Potential Effects of 6PPDQ on Prostate Cancer Through Network Toxicology and Molecular Docking.通过网络毒理学和分子对接研究6PPDQ对前列腺癌的潜在影响。
Toxics. 2024 Dec 8;12(12):891. doi: 10.3390/toxics12120891.
5
Aspartame carcinogenic potential revealed through network toxicology and molecular docking insights.通过网络毒理学和分子对接的见解揭示阿斯巴甜的致癌潜力。
Sci Rep. 2024 May 20;14(1):11492. doi: 10.1038/s41598-024-62461-w.
6
Traditional medicine consumption in postpartum for HBV-infected women enrolled in the ANRS 12345 TA PROHM study in Cambodia.柬埔寨 ANRS 12345 TA PROHM 研究中,感染乙肝病毒的产妇产后采用传统医学治疗情况。
PLoS One. 2023 Aug 10;18(8):e0288389. doi: 10.1371/journal.pone.0288389. eCollection 2023.
7
Jaundice and its associated factors among neonates admitted to selected referral hospitals in southwest oromia, Ethiopia: Multi-center cross-sectional study.埃塞俄比亚奥罗米亚西南部选定转诊医院收治的新生儿黄疸及其相关因素:多中心横断面研究。
Heliyon. 2023 May 4;9(5):e16019. doi: 10.1016/j.heliyon.2023.e16019. eCollection 2023 May.
8
A review of herb-induced liver injury in mainland china.中国大陆草药性肝损伤的综述。
Front Pharmacol. 2022 Oct 11;13:813073. doi: 10.3389/fphar.2022.813073. eCollection 2022.
9
Nakai-Induced Liver Injury-A Mechanistic Study Using Untargeted Metabolomics.中井诱导的肝损伤——一项使用非靶向代谢组学的机制研究。
Front Pharmacol. 2022 Jul 13;13:934057. doi: 10.3389/fphar.2022.934057. eCollection 2022.
10
Metabolic Activation of the Toxic Natural Products From Herbal and Dietary Supplements Leading to Toxicities.草药和膳食补充剂中有毒天然产物的代谢活化导致毒性。
Front Pharmacol. 2021 Oct 20;12:758468. doi: 10.3389/fphar.2021.758468. eCollection 2021.
墨西哥草药:一种肝毒性的原因。批判性综述。
Int J Mol Sci. 2016 Feb 15;17(2):235. doi: 10.3390/ijms17020235.
4
Clinical Features of Drug-induced Liver Injury According to Etiology.药物性肝损伤按病因分类的临床特征。
J Korean Med Sci. 2015 Dec;30(12):1815-20. doi: 10.3346/jkms.2015.30.12.1815. Epub 2015 Nov 30.
5
Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.基于证据链的肝损伤中药相关性鉴定:以著名的肝修复中药何首乌为例。
Front Med. 2015 Dec;9(4):457-67. doi: 10.1007/s11684-015-0417-8. Epub 2015 Oct 12.
6
Traditional Chinese Medicine Induced Liver Injury.中药导致的肝损伤。
J Clin Transl Hepatol. 2014 Jun;2(2):80-94. doi: 10.14218/JCTH.2014.00003. Epub 2014 Jun 15.
7
Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.药物和草药引起的肝损伤:进展、当前挑战及上市后风险的新信号
World J Hepatol. 2015 Jul 8;7(13):1761-71. doi: 10.4254/wjh.v7.i13.1761.
8
Herbal hepatotoxicity: current status, examples, and challenges.草药肝毒性:现状、实例与挑战。
Expert Opin Drug Metab Toxicol. 2015;11(10):1551-65. doi: 10.1517/17425255.2015.1064110. Epub 2015 Jul 6.
9
[Comparison of processed and crude Polygoni Multiflori Radix induced rat liver injury and screening for sensitive indicators].[制何首乌与生何首乌致大鼠肝损伤的比较及敏感指标筛选]
Zhongguo Zhong Yao Za Zhi. 2015 Feb;40(4):654-60.
10
Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds.何首乌及其分离的生物活性化合物的临床研究综述。
Pharmacognosy Res. 2015 Jul-Sep;7(3):225-36. doi: 10.4103/0974-8490.157957.